1PG Stock Chart & Stats
€9.27
€0.08(1.49%)
At close: 4:00 PM EST
€9.27
€0.08(1.49%)
Day’s Range― - ―
52-Week Range€6.28 - €10.36
Previous CloseN/A
Volume0.00
Average Volume (3M)16.00
Market Cap
€853.30M
Enterprise Value€10.30K
Total Cash (Recent Filing)€15.00M
Total Debt (Recent Filing)€147.50M
Price to Earnings (P/E)―
Beta0.85
Next Earnings
Oct 29, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.35
Shares Outstanding87,723,526
10 Day Avg. Volume0
30 Day Avg. Volume16
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Aker BioMarine ASA News
1PG FAQ
What was Aker BioMarine ASA’s price range in the past 12 months?
Aker BioMarine ASA lowest stock price was €6.28 and its highest was €10.36 in the past 12 months.
What is Aker BioMarine ASA’s market cap?
Aker BioMarine ASA’s market cap is €853.30M.
When is Aker BioMarine ASA’s upcoming earnings report date?
Aker BioMarine ASA’s upcoming earnings report date is Oct 29, 2026 which is in 95 days.
How were Aker BioMarine ASA’s earnings last quarter?
Aker BioMarine ASA released its earnings results on Jul 10, 2026. The company reported -€0.053 earnings per share for the quarter, missing the consensus estimate of €0.031 by -€0.083.
Is Aker BioMarine ASA overvalued?
According to Wall Street analysts Aker BioMarine ASA’s price is currently Overvalued.
Does Aker BioMarine ASA pay dividends?
Aker BioMarine ASA does not currently pay dividends.
What is Aker BioMarine ASA’s EPS estimate?
Aker BioMarine ASA’s EPS estimate is 0.04.
How many shares outstanding does Aker BioMarine ASA have?
Aker BioMarine ASA has 87,723,526 shares outstanding.
What happened to Aker BioMarine ASA’s price movement after its last earnings report?
Aker BioMarine ASA reported an EPS of -€0.053 in its last earnings report, missing expectations of €0.031. Following the earnings report the stock price went down -3.163%.
Which hedge fund is a major shareholder of Aker BioMarine ASA?
Currently, no hedge funds are holding shares in DE:1PG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aker BioMarine ASA
Aker BioMarine AS, a subsidiary of Aker ASA, is a Norwegian company established in 2006 and headquartered in Lysaker. The firm is dedicated to the global development, production, and commercialization of ingredients sourced from krill, serving diverse applications in nutraceuticals, dietary supplements, and animal feed. Its market reach extends across Norway, the Americas, Asia Pacific, Europe, the Middle East, and Africa. The company operates through two distinct segments: Ingredients and Brands. Its product portfolio features Superba, a krill-derived nutraceutical ingredient recognized for its phospholipid complex containing choline, omega-3s, and astaxanthin. Other key offerings include QRILL Aqua, designed for aquaculture, and QRILL Pet, tailored for animal feed. Aker BioMarine also provides LYSOVETA, an innovative delivery platform based on LPC-bound EPA and DHA from krill, alongside INVI, a hydrolyzed protein isolate suitable for food and beverage applications. Beyond its core ingredient business, the company distributes natural supplements and various human health and nutrition products. Furthermore, it oversees AION, a circular solutions provider focused on waste recycling and material reuse.